Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Small extracellular vesicles from young adipose-derived stem cells ameliorate age-related changes in the heart of old mice.

Sanz-Ros J., Huete-Acevedo J., Mas-Bargues C., Romero-García N., Dromant M., van Weeghel M.

Animal Study on Cardiovascular Disease, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Stem Cell Res Ther (2025)
Country
England
Reported sample size
—
Source database
PubMed
PMID
40082997
PMCID
PMC11907833
DOI
10.1186/s13287-025-04255-z
Citations
2

Abstract (original English)

Background: Aging is a process characterized by a progressive decline in physiological functions. This decline contributes to an increased risk of various age-related diseases, including conditions such as heart failure or aortic stenosis. Recent advances have highlighted the potential of stem cell therapies in mitigating the adverse effects of aging. The mechanisms underlying the therapeutic effects of these cells appear to be largely paracrine, including the exchange of different molecules via extracellular vesicles (EVs). This work aims to investigate the potential of sEVs derived from young adipose-derived stem cells (ADSC-sEVs) in restoring structural, molecular, and functional changes associated with aging in the heart. Methods: Aged C57BL/6J mice were treated intravenously with ADSC-sEVs from young mice or PBS as controls, young mice were also included to identify specific changes associated with aging. The impact of sEV treatment on cardiac function was assessed using transthoracic echocardiography and physical endurance tests. Histological and molecular analyses were conducted on heart tissue to evaluate structural changes and markers of senescence, inflammation, and oxidative stress. Additionally, a comprehensive metabolomic analysis was performed on heart tissues to identify changes in metabolic profiles associated with aging and treatment status. Results: Administra

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsExtracellular VesiclesMiceMice, Inbred C57BLAgingMyocardiumStem CellsMaleCellular SenescenceAdipose Tissue

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research